Skip to main content

UTHealth Houston Logo

Here for our community and beyond.

We're here to serve our community. Find where to get your COVID-19 vaccine today through UT Physicians.

Read More from the Front Lines of COVID-19

Photo of Zhiqiang An, PhD, who was one of the lead authors of a study that revealed engineered IgM antibodies were more potent than standard ones against COVID-19. (Photo by UTHealth)

Preclinical research reveals that new IgM antibodies administered intranasally to fight COVID-19 more potent than commonly used ones

June 3, 2021 | Jeannette Sanchez

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. 

More from the Front Lines

Videos

UT Physicians

Visit with a primary or specialty care provider at one of our many locations or from the comfort of your home through our telehealth platform. Our clinics are open with expanded safety measures and ready to provide you with exceptional patient care. Telehealth visits are also available for any non-emergency and urgent care need.

Schedule your telehealth appointment:
https://www.utphysicians.com/telehealth

Schedule an appointment at one of our many locations:
https://www.utphysicians.com/patients/appointment/

UTHealth Houston team designs face shields for COVID-19 response

With cake collar material, a three-hole punch, a scrapbooking paper trimmer, and the drive to protect those on the front lines of health care, a team from UTHealth Houston has designed a face shield that can be used by thousands of providers in the Texas Medical Center.

UTHealth Houston In the Headlines

UTHealth Houston has been on the frontlines of the COVID-19 pandemic. Our experts have helped shape local and state responses to the pandemic, and our researchers have been conducting clinical trials and researching the mechanics of the virus.

June 3, 2021
Preclinical research reveals that new IgM antibodies administered intranasally to fight COVID-19 more potent than commonly used ones